SANDREAM IMPACT LLC – Trademark Portfolio
Entity Type: 16
SANDREAM IMPACT LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 2 (Paints) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SYNMIRA, MICAMIRA, SANDREAM, GLASSMIRA, and SILIKMIRA. The owner is based in FAIRFIELD, NJ.
373 RT. 46 W, BUILDING E
FAIRFIELD, NJ 07004
Showing of trademarks Trademarks
Trademark Classifications
SANDREAM IMPACT LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SANDREAM IMPACT LLC have?
SANDREAM IMPACT LLC has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 1 cancelled.
What trademark classes does SANDREAM IMPACT LLC file in?
SANDREAM IMPACT LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 2 (Paints), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.
What are SANDREAM IMPACT LLC's most well-known trademarks?
SANDREAM IMPACT LLC's registered trademark portfolio includes well-known marks such as SYNMIRA, MICAMIRA, SANDREAM, GLASSMIRA, and SILIKMIRA. These are among 6 currently registered trademarks in the portfolio.
What is SANDREAM IMPACT LLC's trademark registration success rate?
SANDREAM IMPACT LLC has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.